← Eichor
Condition: Kcnt1 Related Epilepsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Kcnt1 Related Epilepsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric Partic
Phase 2 · 1 location(s) · Actio Biosciences, Inc. · NCT07600736A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in
Phase 1 · 1 location(s) · Actio Biosciences, Inc. · NCT07156201A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopath
Phase 1/Phase 2 · 16 location(s) · Institut de Recherches Internationales Servier · NCT07227857
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.